Genesis Healthcare Inc Stock Forecast for 2023 - 2025 - 2030
Updated on 04/26/2024
Genesis Healthcare Inc Stock Forecast and Price Target
If the average price target of $26.43 set by distinguished experts for Genesis Healthcare Inc over the past few weeks is reached this year, there would be a potential upside of approximately 28.61% from the last closing price in April, 2024. This potential increase is based on a high estimate of $29.00 and a low estimate of $21.00. Even if not interested in GEN stock, you may want to be aware of its competitors.
28.61% Upside
Genesis Healthcare Inc Fair Value Forecast for 2023 - 2025 - 2030
In the last five years, Genesis Healthcare Inc's Price has decreased by 100.00%, from $13.75 to $0.00. Next year, analysts are expecting Fair Value to reach $29.80 – an increase of 100.00%. Over the next six years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MSFT Stock Forecast | Microsoft Corp | Buy |
18
|
$399.04 | Buy/Sell | $465.63 | 19.04% |
| CRM Stock Forecast | Salesforce | Outperform |
14
|
$273.14 | Buy/Sell | $285.37 | 25.94% |
| INTU Stock Forecast | Intuit Inc | Outperform |
11
|
$626.39 | Buy/Sell | $678.62 | 14.94% |
| NOW Stock Forecast | ServiceNow | Outperform |
12
|
$716.25 | Buy/Sell | $832.11 | 18.12% |
| SNPS Stock Forecast | Synopsys | Outperform |
9
|
$530.11 | Buy/Sell | $611.27 | 20.17% |
Genesis Healthcare Inc Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Genesis Healthcare Inc's Revenue has grown from $2.49B to $3.34B – a 34.06% increase. For the next year, 1 analysts project Genesis Healthcare Inc's Revenue to drop by 6.51%, reaching $3.12B. Over the next six years, the forecast is for Revenue to grow by 16.03%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CDNS Stock Forecast | Cadence Design Systems | Outperform |
8
|
$277.08 | Buy/Sell | $315.45 | 17.66% |
| NasdaqGS:ATVI Stock Forecast | Activision Blizzard | - |
6
|
$93.63 | Buy/Sell | $95.20 | -100.00% |
| EA Stock Forecast | Electronic Arts Inc | Outperform |
9
|
$127.31 | Buy/Sell | $151.94 | 17.82% |
.jpg)
Genesis Healthcare Inc Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Genesis Healthcare Inc's Dividend per Share has grown by 25.00%, rising from $0.40 to $0.50. According to 1 prominent analysts, Genesis Healthcare Inc's Dividend per Share will fall by 0.00% in the next year, reaching $0.50. Over the next six years, experts predict that Genesis Healthcare Inc's Dividend per Share will grow at a rate of 1.37%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ANSS Stock Forecast | ANSYS | Hold |
16
|
$327.04 | Buy/Sell | $349.37 | 6.26% |
| SPLK Stock Forecast | Splunk | - |
7
|
$156.50 | Buy/Sell | $144.17 | -100.00% |
| TTWO Stock Forecast | Take-Two Interactive Software | Outperform |
12
|
$143.43 | Buy/Sell | $176.42 | 24.80% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PTC Stock Forecast | PTC | Outperform |
15
|
$179.88 | Buy/Sell | $182.20 | 11.74% |
| MSTR Stock Forecast | MicroStrategy | Outperform |
11
|
$1.24k | Buy/Sell | $669.50 | 31.01% |
| NUAN Stock Forecast | Nuance Communications | - |
12
|
$55.99 | Buy/Sell | $56.00 | -100.00% |
Genesis Healthcare Inc EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Genesis Healthcare Inc's EBITDA has grown, rising from $821.00M to $1.57B – a growth of 90.74%. In the next year, analysts believe that EBITDA will reach $1.67B – an increase of 6.82%. For the next six years, the forecast is for EBITDA to grow by 57.89%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SSNC Stock Forecast | SS&C Technologies Holdings | Outperform |
18
|
$61.31 | Buy/Sell | $70.57 | 15.80% |
| CTXS Stock Forecast | Citrix Systems | - |
13
|
$103.90 | Buy/Sell | $105.86 | -58.20% |
| AZPN Stock Forecast | AspenTech | - |
16
|
$166.30 | Buy/Sell | $152.67 | -100.00% |
Genesis Healthcare Inc EBIT Forecast for 2023 - 2025 - 2030
Genesis Healthcare Inc's EBIT has grown In the last three years, rising from $620.00M to $1.37B – a growth of 121.45%. In the next year, analysts believe that EBIT will reach $1.66B – an increase of 21.04%. For the next six years, experts predict that Genesis Healthcare Inc's EBIT will grow at a rate of 44.92%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PFPT Stock Forecast | Proofpoint | - |
10
|
$175.90 | Buy/Sell | $176.00 | -100.00% |
| ESTC Stock Forecast | Elastic N.V. | Outperform |
8
|
$104.79 | Buy/Sell | $82.72 | 27.25% |
| ZNGA Stock Forecast | Zynga | - |
14
|
$8.18 | Buy/Sell | $9.27 | -100.00% |
Genesis Healthcare Inc EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last five years, Genesis Healthcare Inc's EPS has decreased by 100.00%, from $0.90 to $0.00. Next year, analysts are expecting EPS to reach $1.95 – an increase of 100.00%. Over the next six years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CHNG Stock Forecast | Change Healthcare | Hold |
11
|
$27.49 | Buy/Sell | $27.75 | 0.95% |
| GWRE Stock Forecast | Guidewire Software | Outperform |
2
|
$111.98 | Buy/Sell | $99.73 | 16.09% |
| RP Stock Forecast | RealPage | - |
16
|
$0.06 | Buy/Sell | $94.88 | 16.67% |
Site Navigation
.jpg)